Per-oral endoscopic myotomy is safe and effective for pediatric patients with achalasia: A long-term follow-up study

doi:10.3748/wjg.v29.i22.3497

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2732)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

1369

Figures (1-1)

270

Tables (1-4)

242

Sum=2007

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

111

Download

259

Sum=370

Publishing Process of This Article

Item

Count

Browse

124

Download

231

Sum=355

Jun 14, 2023 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jun 14, 2023; 29(22): 3497-3507
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3497

Table 1 General characteristics of the pediatric group and the control group

		Pediatric group (n = 48)	Control group (n = 1025)	P value
Sex, n (%)
Male		26 (54.2)	469 (45.8)	0.253
Female		22 (45.8)	556 (54.2)
Age, median (range), years		16 (7-18)	43 (19-65)	< 0.001
BMI, median (range), kg/m²		17.7 (11.2-26.8)	20.9 (12.9-40.4)	< 0.001
Chicago classification, n (%)		n = 42, 87.5	n = 1003, 97.8	0.928
	Type I	7 (16.7)	156 (15.5)
	Type II	32 (76.2)	787 (78.5)
	Type III	3 (7.1)	60 (6.0)
Ling classification, n (%)				0.076
	Ling I	9 (18.8)	189 (17.0)
	Ling IIa	17 (35.4)	340 (30.6)
	Ling IIb	18 (37.5)	249 (22.4)
	Ling IIc	4 (8.3)	206 (18.5)
	Ling III	0 (0.0)	41 (1.35)
Disease course, median (range), month		17.5 (2-120)	48 (1-540)	< 0.001
LES pressure, median (range), mmHg		n = 42, 87.5	n = 1003, 97.8	0.214
LES pressure, median (range), mmHg		25.8 (8.4-65.9)	24.5 (1-83.2)	0.214
Prior treatment				0.210
Patients without prior treatment, n (%)		36 (75.0)	842 (82.1)
Patients with prior treatment, n (%)		12 (25.0)	183 (17.9)
	BTI	4 (8.3)	46 (4.5)
	PBD	5 (10.4)	92 (9.0)
	POEM	1 (2.1)	9 (0.9)
	LHM	0 (0.0)	10 (1.0)
	ESP	0 (0.0)	14 (1.4)
	PBD + BTI	1 (2.1)	3 (0.3)
	ESP + BTI	1 (2.1)	1 (0.1)
	POEM + PBD	0 (0.0)	2 (0.2)
	PBD + ESP	0 (0.0)	3 (0.3)
	PBD + LHM	0 (0.0)	1 (0.1)
	BTI + LHM	0 (0.0)	1 (0.1)
	ESP + LHM	0 (0.0)	1 (0.1)

BTI: Botulinum toxin injection; BMI: Body mass index; PBD: Pneumatic balloon dilation; POEM: Per-oral endoscopic myotomy; LHM: Laparoscopic Heller myotomy; ESP: Endoscopic stent placement; LES: Lower esophageal sphincter.

Citation: Bi YW, Lei X, Ru N, Li LS, Wang NJ, Zhang B, Yao Y, Linghu EQ, Chai NL. Per-oral endoscopic myotomy is safe and effective for pediatric patients with achalasia: A long-term follow-up study. World J Gastroenterol 2023; 29(22): 3497-3507
URL: https://www.wjgnet.com/1007-9327/full/v29/i22/3497.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i22.3497